United States Biotechnology & Medical Research

Poseida Therapeutics, Inc. (PSTX)

Track

Track

Ticker: PSTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Poseida Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gergen Mark J Executive Chairman Executive Director
Transaction date
Planned sale
Price
459.63
Quantity 30,519 +22.0%
Value US$4,995,677
Gergen Mark J Executive Chairman Executive Director
Transaction date
Planned sale
Price
437.66
Quantity 55,677 -3.9%
Value US$2,998,348
MARK GERGEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
142.78
Quantity 6,063
Value US$713,371
Ostertag Eric Executive Chairman Executive Director Large shareholder
Transaction date
Planned purchase
Price
3.50
Quantity 142,857 +20.5%
Value US$500,000
3.3
Malin Life Sciences Holdings Ltd Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 2,150,000 +22.2%
Value US$7,525,000
Ostertag Eric Executive Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
3.69
Quantity 160,696 -100.0%
Value US$592,808
1.1
Ingalls Kerry D. Chief Operating Officer Officer
Transaction date
Purchase
Price
3.98
Quantity 3,000 +5.8%
Value US$11,940
1.1
Ingalls Kerry D. Chief Operating Officer Officer
Transaction date
Purchase
Price
7.00
Quantity 2,000 +inf%
Value US$14,000
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
7.09
Quantity 9,051 -0.3%
Value US$64,172
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
7.09
Quantity 9,873 -0.3%
Value US$70,000
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
7.02
Quantity 9,579 -0.3%
Value US$67,245
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
7.02
Quantity 10,450 -0.3%
Value US$73,359
Spear Matthew A. Chief Medical Officer Officer
Transaction date
Planned sale
Price
9.44
Quantity 4,000 -19.5%
Value US$37,747
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
8.44
Quantity 17,211 -0.5%
Value US$145,261
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
8.44
Quantity 18,775 -0.5%
Value US$158,461
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.01
Quantity 8,765 -0.2%
Value US$78,973
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.01
Quantity 9,561 -0.2%
Value US$86,145
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.32
Quantity 1,483 -0.0%
Value US$15,307
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.63
Quantity 26,170 -0.7%
Value US$251,886
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.32
Quantity 1,617 -0.0%
Value US$16,691
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.63
Quantity 28,549 -0.7%
Value US$274,784
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.55
Quantity 27,347 -0.8%
Value US$261,284
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
9.55
Quantity 29,834 -0.8%
Value US$285,046
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
11.54
Quantity 27,290 -0.8%
Value US$314,899
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
11.54
Quantity 29,770 -0.8%
Value US$343,516
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
12.12
Quantity 484 -0.0%
Value US$5,866
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
11.66
Quantity 27,226 -0.7%
Value US$317,455
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
12.12
Quantity 528 -0.0%
Value US$6,399
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
11.66
Quantity 29,702 -0.7%
Value US$346,325
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.00
Quantity 133,149 -39.9%
Value US$1,332,036
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.00
Quantity 12,389 -3.6%
Value US$123,890
Ostertag Eric Chief Executive Officer Executive Director Large shareholder
Transaction date
Planned sale
Price
10.00
Quantity 4,462 -1.3%
Value US$44,620
1.2
Hirsch David Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 250,000 +10.1%
Value US$4,000,000
3.2
Murphy Sean Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 10,000 +inf%
Value US$160,000
Lloyd Marcea Bland Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 10,000 +inf%
Value US$160,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-11 2024-12-10 PlS Planned sale
Gergen Mark J

Executive Chairman

Executive Director
30,519 +22.0%
459.63
US$4,995,677 		30,519 +22.0% 459.63 US$4,995,677
2024-11-27 2024-11-26 PlS Planned sale
Gergen Mark J

Executive Chairman

Executive Director
55,677 -3.9%
437.66
US$2,998,348 		55,677 -3.9% 437.66 US$2,998,348
2024-11-26 2024-11-26 PrS Proposed sale
MARK GERGEN

Director; Officer

Executive Director
6,063
142.78
US$713,371 		6,063 142.78 US$713,371
2022-08-10 2022-08-08 PP Planned purchase
Ostertag Eric

Executive Chairman

Executive Director Large shareholder
142,857 +20.5%
3.50
US$500,000 		142,857 +20.5% 3.50 US$500,000
2022-08-10 2022-08-08 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
2,150,000 +22.2%
3.50
US$7,525,000 		2,150,000 +22.2% 3.50 US$7,525,000
2022-08-05 2022-08-03 PlS Planned sale
Ostertag Eric

Executive Chairman

Executive Director Large shareholder
160,696 -100.0%
3.69
US$592,808 		160,696 -100.0% 3.69 US$592,808
2022-03-18 2022-03-16 B Purchase
1.1
Ingalls Kerry D.

Chief Operating Officer

Officer
3,000 +5.8%
3.98
US$11,940 		3,000 +5.8% 3.98 US$11,940
2021-12-07 2021-12-06 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
1,828 +0.0%
6.90
US$12,613 		1,828 +0.0% 6.90 US$12,613
2021-12-02 2021-12-02 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
4,296 +0.0%
6.88
US$29,550 		4,296 +0.0% 6.88 US$29,550
2021-12-02 2021-12-01 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
18,365 +0.2%
6.85
US$125,806 		18,365 +0.2% 6.85 US$125,806
2021-12-02 2021-11-30 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
28,592 +0.3%
6.85
US$195,838 		28,592 +0.3% 6.85 US$195,838
2021-11-29 2021-11-29 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
11,057 +0.1%
6.89
US$76,209 		11,057 +0.1% 6.89 US$76,209
2021-11-29 2021-11-26 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
27,251 +0.3%
6.81
US$185,492 		27,251 +0.3% 6.81 US$185,492
2021-11-29 2021-11-24 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
1,054 +0.0%
6.89
US$7,260 		1,054 +0.0% 6.89 US$7,260
2021-11-23 2021-11-23 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
14,625 +0.2%
6.77
US$98,989 		14,625 +0.2% 6.77 US$98,989
2021-11-23 2021-11-19 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
11,104 +0.1%
7.44
US$82,650 		11,104 +0.1% 7.44 US$82,650
2021-11-18 2021-11-18 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
71,312 +0.8%
7.18
US$511,685 		71,312 +0.8% 7.18 US$511,685
2021-11-18 2021-11-17 B Purchase
1.1
Ingalls Kerry D.

Chief Operating Officer

Officer
2,000 +inf%
7.00
US$14,000 		2,000 +inf% 7.00 US$14,000
2021-11-18 2021-11-17 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
280,384 +3.0%
7.21
US$2,021,821 		280,384 +3.0% 7.21 US$2,021,821
2021-11-18 2021-11-16 B Purchase
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
27,680 +0.3%
7.17
US$198,383 		27,680 +0.3% 7.17 US$198,383
2021-11-10 2021-11-08 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,051 -0.3%
7.09
US$64,172 		9,051 -0.3% 7.09 US$64,172
2021-11-10 2021-11-08 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,873 -0.3%
7.09
US$70,000 		9,873 -0.3% 7.09 US$70,000
2021-10-05 2021-10-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,579 -0.3%
7.02
US$67,245 		9,579 -0.3% 7.02 US$67,245
2021-10-05 2021-10-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
10,450 -0.3%
7.02
US$73,359 		10,450 -0.3% 7.02 US$73,359
2021-06-14 2021-06-11 PlS Planned sale
Spear Matthew A.

Chief Medical Officer

Officer
4,000 -19.5%
9.44
US$37,747 		4,000 -19.5% 9.44 US$37,747
2021-05-05 2021-05-04 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
17,211 -0.5%
8.44
US$145,261 		17,211 -0.5% 8.44 US$145,261
2021-05-05 2021-05-04 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
18,775 -0.5%
8.44
US$158,461 		18,775 -0.5% 8.44 US$158,461
2021-05-05 2021-05-03 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
8,765 -0.2%
9.01
US$78,973 		8,765 -0.2% 9.01 US$78,973
2021-05-05 2021-05-03 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
9,561 -0.2%
9.01
US$86,145 		9,561 -0.2% 9.01 US$86,145
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
1,483 -0.0%
10.32
US$15,307 		1,483 -0.0% 10.32 US$15,307
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
26,170 -0.7%
9.63
US$251,886 		26,170 -0.7% 9.63 US$251,886
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
1,617 -0.0%
10.32
US$16,691 		1,617 -0.0% 10.32 US$16,691
2021-04-05 2021-04-05 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
28,549 -0.7%
9.63
US$274,784 		28,549 -0.7% 9.63 US$274,784
2021-04-05 2021-04-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,347 -0.8%
9.55
US$261,284 		27,347 -0.8% 9.55 US$261,284
2021-04-05 2021-04-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,834 -0.8%
9.55
US$285,046 		29,834 -0.8% 9.55 US$285,046
2021-03-03 2021-03-02 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,290 -0.8%
11.54
US$314,899 		27,290 -0.8% 11.54 US$314,899
2021-03-03 2021-03-02 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,770 -0.8%
11.54
US$343,516 		29,770 -0.8% 11.54 US$343,516
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
484 -0.0%
12.12
US$5,866 		484 -0.0% 12.12 US$5,866
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
27,226 -0.7%
11.66
US$317,455 		27,226 -0.7% 11.66 US$317,455
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
528 -0.0%
12.12
US$6,399 		528 -0.0% 12.12 US$6,399
2021-03-03 2021-03-01 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
29,702 -0.7%
11.66
US$346,325 		29,702 -0.7% 11.66 US$346,325
2021-02-17 2021-02-16 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
133,149 -39.9%
10.00
US$1,332,036 		133,149 -39.9% 10.00 US$1,332,036
2021-02-12 2021-02-10 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
12,389 -3.6%
10.00
US$123,890 		12,389 -3.6% 10.00 US$123,890
2021-01-25 2021-01-21 PlS Planned sale
Ostertag Eric

Chief Executive Officer

Executive Director Large shareholder
4,462 -1.3%
10.00
US$44,620 		4,462 -1.3% 10.00 US$44,620
2020-07-15 2020-07-14 B Purchase
1.2
Hirsch David
Non-Executive Director
250,000 +10.1%
16.00
US$4,000,000 		250,000 +10.1% 16.00 US$4,000,000
2020-07-15 2020-07-14 B Purchase
3.2
Murphy Sean
Non-Executive Director Large shareholder
10,000 +inf%
16.00
US$160,000 		10,000 +inf% 16.00 US$160,000
2020-07-15 2020-07-14 B Purchase
Lloyd Marcea Bland
Non-Executive Director
10,000 +inf%
16.00
US$160,000 		10,000 +inf% 16.00 US$160,000
Explore more

More insider trading research around Poseida Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America